BeStock  
Stocks › Biotechnology › BLTE

Belite Bio BLTE

US equityMarket cap rank #2018Biotechnology
$127.38 −$23.64 (-15.65%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $127.38 0.00%
Open$129.00
Prev close$151.02
Day range$120.00 – $135.07
Volume1.04M
Market cap$5.17B
P/E (TTM)–
Dividend yield–

Price chart

Daily bars for up to one year, weekly bars for the 5-year view. Averages are 50/200 trading days (10/40 weeks on the 5-year view). Triangles mark past earnings reports, colored by that day’s move; ticks mark ex-dividend dates — hover either for the date. Volume is the shaded bars under the price; switch on RSI or MACD above for a full-history oscillator panel, or Bollinger Bands for the same 20-day/2-standard-deviation channel used in the Technical signals table.

BLTE at a glance

BLTE last changed hands at $127.38 (down 15.65%). At $5.17B, Belite Bio is ranked #2018 by size among the 3753 stocks on BeStock.

The 52-week range is $115.41 to $200.00. Today's price is about 14% of the way from the low to the high. Holders are ahead 5.7% over twelve months, but down 19.8% across the last three months.

On the chart it has slipped under both the 50-day ($157.61) and 200-day ($159.43) moving averages; RSI is 32, and the last 30 sessions moved at roughly 74% annualized volatility.

Revenue for the quarter ended Sep 2026 was $0.00, and a net loss of $30.27M.

6 analysts follow the stock and the average call is "buy". The mean target, $231.67, sits 81.9% over where the stock trades.

This summary is put together from the numbers on the page and updates when they do. It describes the data; it is not a forecast or a recommendation.

Key statistics

Bid / Ask$123.00 / $148.00
Average price today$129.94
Volume1.04MAvg (90d) 189.8K
Turnover$134.88M
Turnover rate5.23%of shares outstanding
Volume ratio6.95vs. recent average pace
Day amplitude9.98%
Market cap$5.17B
Float market cap$2.53B
Shares outstanding19.85M
EPS (TTM)-$2.31
P/B6.71
Book value / share$18.99
Net profit (TTM)-$93.82M
Net assets$771.06M
30-day volatility74.4%annualized
Avg daily range (ATR)8.14%of price, 14 days
Max drawdown (1y)-34.2%-34.2% from 1y peak

Quote as of Nov 20, 2026 8:10 pm ET. Prices can lag the live tape. This is background information, not a recommendation.

BeStock Grade

C
BeStock Grade

Composite of 3 factors below, ranked against the 3734 U.S. stocks BeStock covers.

C
Valuation

Cheaper than usual on its own 5-year P/E history scores higher.

D
Momentum

Trading closer to its 52-week high than most peers scores higher.

B
Wall Street

6 analysts, consensus Buy.

How this is scored: each factor above is a 0–100 percentile rank against every other stock BeStock covers (or, for Wall Street, against the five-point Strong Buy–Sell scale). The overall grade is the plain average of whichever factors apply to this stock — no factor is weighted more than another. That average maps to a letter: A ≥ 85, B ≥ 70, C ≥ 50, D ≥ 30, otherwise F. Recomputed from the data on this page as prices and filings update — it describes where a stock ranks today, not a forecast, and not a BeStock recommendation to buy or sell.

Six-factor research snapshot

Overall percentile: 42.8 · 2026-11-22 08:27 UTC. Higher values indicate a stronger relative ranking.

FactorPercentile
Valuation—
Growth—
Profitability8.6
Momentum37.9
Financial health80.8
Analyst view87.6

Price forecast

What Wall Street analysts and Morningstar's fair-value model expect for the stock

Analyst price target (avg)$231.67+81.9% vs. current price
Consensus ratingBuy6 analysts covering
Morningstar fair value$156.06Price is below fair value

Wall Street’s average 12-month target is $231.67, 81.9% above today’s price, with a consensus rating of Buy. Morningstar’s fair value model puts the stock at $156.06, so shares trade 18.4% below that estimate. On earnings multiple, it sits in the 40th percentile of its own five-year valuation range (cheaper than usual).

Figures are Wall Street analyst consensus and Morningstar’s independent fair-value model, sourced as noted above.

Performance

Price return over each window, from adjusted daily and weekly closes

1 day
-15.7%
1 week
-22.5%
1 month
-15.2%
3 months
-19.8%
6 months
-7.2%
Year to date
-20.4%
1 year
+5.7%
Day range
$120.00$135.07
52-week range
$115.41$200.00

Technical signals

Full technicals →
Trend readStrong downtrend

0 bullish · 6 bearish of 7 signals

IndicatorValueSignal
Price vs 20-day average-16.7%Bearish
Price vs 50-day average-19.2%Bearish
Price vs 200-day average-20.1%Bearish
50-day vs 200-day50d below 200dBearish
RSI (14)31.6Bearish
MACD (12,26,9)-1.80Bearish
Bollinger band position-22%Neutral

Standard indicator readings worked out from daily closes. They describe how the price has behaved, not where it is going.

How BLTE ranks on BeStock

Market value#2012 of 3734
Closeness to 52-week high#2512 of 3724
Dollar volume today#842 of 3734

Ranks are among the 3,734 or so U.S.-listed stocks BeStock covers, recalculated whenever prices refresh. A tile is left out when the measure does not apply, such as yield for a stock that pays no dividend.

BLTE is not currently one of the 10 holdings in BeStock Momentum, our rules-based momentum strategy.

Since 2020-12-28, the strategy has returned 401.7% (183.6% for the equal-weight average of BeStock’s coverage over the same stretch). Holdings can change any trading day, not just on a fixed schedule. Backtested performance, updated daily — not a guarantee of future results, and not a BeStock recommendation.

Strategy Backtest

Pick a strategy above and run the backtest to see its simulated performance on BLTE.

Rule-based technical strategies computed from this stock’s own price history only. Signals use only data available through the prior trading day (no look-ahead), and trading costs, slippage and taxes aren’t modeled. A backtested rule performing well in the past is not a guarantee of future results — this is an educational illustration, not investment advice.

Community Sentiment on BLTE

No votes yet — be the first to weigh in.

Reader sentiment, not investment advice. One vote per visitor; click again to change it.

BLTE stock: common questions

Where is BLTE trading right now?

$127.38 is the latest print for BLTE, a move of -15.65% against yesterday's close of $151.02. Today's low and high so far: $120.00 and $135.07.

What is BLTE worth in total?

Equity value comes to $5.17B at the current price. By that measure it is number 2018 of the 3753 names in our coverage.

Where does BLTE sit in its 52-week range?

The year's floor is $115.41 and the ceiling $200.00. Shares are 36.3% away from that ceiling.

Does BLTE send cash back through a dividend?

Our data shows no dividend paid by Belite Bio over the trailing twelve months.

Do Wall Street analysts like BLTE?

Of 6 analysts, 100% say buy, 0% hold and 0% sell. Price targets average $231.67, with the most cautious at $200.00 and the most optimistic at $303.00.

BeStock publishes market data and analysis for information only. Nothing here is investment advice or a solicitation to buy or sell any security, and none of it is tailored to your financial situation, goals, or risk tolerance. Quotes may be delayed and figures can contain errors; check primary sources before you trade. How we source and calculate these pages.

Discussion

No comments yet — be the first to weigh in on BLTE.

Sign in to join the discussion.

Scroll to Top